首页> 外文期刊>Memorias do Instituto Oswaldo Cruz >Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil
【24h】

Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil

机译:巴西中部肾移植受者中丙型肝炎病毒感染的流行病学方面

获取原文
           

摘要

An investigation was conducted involving 255 renal transplant recipients in the state of Goiás, Central Brazil, to determine the prevalence of hepatitis C virus (HCV), its risk factors, the genotypes involved, and the level of alanine aminotransferase (ALT) present in the patients. All serum samples were tested for anti-HCV antibodies and HCV RNA. Forty-one patients were anti-HCV and/or HCV RNA positive, resulting in an overall HCV infection prevalence of 16.1% (95% CI: 11.9-21.3). A multivariate analysis of risk factors showed that a history of blood transfusions without anti-HCV screening, the length of time spent on hemodialysis, and renal transplantation before 1994 are all associated with HCV positivity. In HCV-positive patients, only 12.2% had ALT levels above normal. Twenty-eight samples were genotyped as genotype 1, subtypes 1a (62.5%) and 1b (31.3%), and two samples (6.2%) were genotype 3, subtype 3a. These data show a high prevalence of HCV infection and low ALT levels in the studied population. The risk factor analysis findings emphasize the importance of public health strategies such as anti-HCV screening of candidate blood and organ donors, in addition to the stricter adoption of hemodialysis-specific infection control measures. The present study also demonstrates that HCV genotype 1 (subtype 1a) is predominant in this population
机译:对巴西中部戈亚斯州的255名肾移植受者进行了一项调查,以确定丙型肝炎病毒(HCV)的患病率,其危险因素,涉及的基因型和丙氨酸转氨酶(ALT)的水平。耐心。测试所有血清样品的抗HCV抗体和HCV RNA。 41名患者的抗HCV和/或HCV RNA阳性,导致HCV总体感染率为16.1%(95%CI:11.9-21.3)。危险因素的多变量分析显示,未进行抗HCV筛查的输血史,血液透析时间长短以及1994年之前的肾移植都与HCV阳性有关。在HCV阳性患者中,只有12.2%的ALT水平高于正常水平。 28个样本的基因型为基因型1,亚型1a(62.5%)和1b(31.3%),两个样本(6.2%)为基因型3,亚型3a。这些数据表明,在研究人群中HCV感染率很高,而ALT水平却很低。危险因素分析结果强调了公共卫生策略的重要性,例如除了严格采用血液透析专用感染控制措施外,还应进行候选血液和器官供体的抗HCV筛查。本研究还表明,HCV基因型1(亚型1a)在该人群中占主导地位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号